Cabergoline for preventing ovarian hyperstimulation syndrome in women at risk undergoingin vitro fertilization/intracytoplasmic sperm injection treatment cycles: A randomized controlled study
Background: Ovarian hyperstimulation syndrome (OHSS) is the most serious and potentially life-threatening iatrogenic complication associated with ovarian stimulation during assisted reproductive technology protocols. The aim of this study was to evaluate the role of dopamine agonist as a preventive...
Guardado en:
Autores principales: | Niyazi Kilic, Özhan Özdemir, Hakan Cevdet Başar, Fadime Demircan, Fırat Ekmez, Oğuz Yücel |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/eb2843cba3aa46cc95007fbbc7b31399 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Effects of Pituitary Surgery and High-Dose Cabergoline Therapy on Metabolic Profile in Patients With Prolactinoma Resistant to Conventional Cabergoline Treatment
por: Rosa Pirchio, et al.
Publicado: (2021) -
RISK FACTORS AND CRITERIA FOR PREDICTION OF OVARIAN HYPERSTIMULATION SYNDROME
por: N. V. Protopopova, et al.
Publicado: (2012) -
A short length of gonadotropin hyperstimulation is sufficient to achieve an optimal IVF outcome in advance-aged women
por: Le Tien Hsu, et al.
Publicado: (2021) -
Electrocatalytic determination of levodopa in presence of cabergoline using carbon paste electrode modified with graphene quantum dots/2-chlorobenzoyl ferrocene/ionic liquid
por: Peyman Mohammadzadeh Jahani
Publicado: (2021) -
Efficacy and Cerebrospinal Fluid Rhinorrhea after Cabergoline Treatment in Patients with Bioactive Macroprolactinoma
por: Hae-Kyung Kim, et al.
Publicado: (2021)